Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2020
Dutch institutions failing to register results of clinical trials
HAI Releases Annual Report 2019
Why TRIPS flexibilities are a crucial mechanism for access to medicines
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
To tackle COVID-19 pandemic, transparency and collaboration are vital
Ensure transparency, affordability and availability of vaccines and treatments for COVID-19, say MEPs
HAI Follows Dutch Government Advice in Response to COVID-19
Europe’s Beating Cancer Plan
Niets magisch aan medicijnprijzen
Nothing magical about medicine prices
US puts pressure on the Netherlands over compulsory licenses
A busy week at the Court of Justice of the European Union
2019
How to measure change in EU Policy
Health Technology Assessments: will 2020 end the deadlock?
Is clinical trial transparency under threat?
REBRAND: Fact or Fiction publication
An insightful day at the EURIPID stakeholder meeting in Budapest
A Momentous Week for Access to Medicines
Dr Marg Ewen Receives the Helen Clark-JoPPP Award
No Universal Health Coverage without Universal Medicines Coverage
2018
A Year at the Heart of Regulatory Decision Making
Staff Spotlight: Jaume Vidal
Time for a Treaty? ReAct Reports on Second Consultation on Global Development & Stewardship Framework to Combat AMR
Medicijnen: de link met de maatschappij
What Role Can Civil Society Play in the European Regulatory Process?
Open Science for Health: Shaping the New Framework Programme
2017